Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • MTT results show that both pancreatic cell

    2019-12-11

    MTT results show that, both pancreatic cell lines were quite sensitive to camptothecin (CPT), a well known topoisomerase I poison. Interestingly, CPT does not show any selectivity over cancer cell lines probably due to the duplication times for cancerous (MIA PaCa-2) and immortalized healthy (HPDEC) cell lines were quite close to each other (40 and 34h, respectively). As it can be seen in Table 1 compound 20 showed five and two times stronger cytotoxic activity compared to compound 3 in MIA PaCa-2 and HPDEC cell lines, respectively. Level of cytotoxic activity of 4′-ethylklavuzon (16a) was stronger compared to 4′-methylklavuzon (3) in both cell lines, but selectivity was getting worse. In general, presence of a linear alkyl chain at position 4′- of klavuzon (3 and 16a–d) caused slightly selective cytotoxic activity for healthy pancreatic cell line (HPDEC). The length of the alkyl chain negatively affected potency of these compounds and shorter alkyl chains resulted more cytotoxic klavuzon derivatives. On the other hand, presence of a more bulky group at 4′- position gave klavuzon derivatives (16e–h) that have comparable potency with 4′-propyl and 4′-butyl substituted klavuzons (16b and 16c). Nevertheless, selectivity index enhanced to 0.91–1.31 interval (Table 1). Induction of apoptosis and SC-10 analysis of MIA PaCa-2 cells treated with varying concentrations of 4′-methylklavuzon (3) were also studied by using Annexin V-FITC apoptosis detection kit (Fig. 4). At the end of 24h of incubation with compound 3 the percentage of the early apoptotic MIA PaCa-2 cells slightly increased by concentration dependent manner. A similar statistically significant amount of increase was observed for the percentage of the late apoptotic cells, while the percentage of the necrotic cells did not change. Besides, cell cycle analysis gave the clues about the existence of more than one action of mechanism for 4′-methylklavuzon (3). Incubation with low dose (1μM) of compound 3 resulted a small increase at G1 phase while that causes a similar amount of decrease at S phase. The number of cells at G1 phase decreased significantly in MIA PaCa-2 cell line incubated with 5 and 10μM of 4′-methylklavuzon for 24h. Contrarily, number of cells at G2 phase increased significantly at the same concentrations. There is a small rise in the number of cells at S phase in the presence of 10μM of 4′-methylklavuzon but this increment was not significant (Fig. 4). Cell cycle arrest at S phase may be the indication of Topo I inhibitory property of 4′-methylklavuzon (3) and it is required high doses of compound 3. In addition, cell cycle arrest at G2 phase could mean that a number of cells complete the DNA duplication and another mechanism blocks the cell division at this stage. According to apoptosis and cell cycle analysis, compound 3 causes apoptosis or cell cycle arrest only in a small fraction of cell population even at 10μM concentration at the end of 24h incubation period. However, IC50 value of compound 3 in MIA PaCa-2 cells was calculated as 0.96μM for 48h treatment. There should be a sign for this cytotoxic effect at 24h incubation. To control DNA integrity comet assay was performed for MIA PaCa-2 cells treated with varying concentrations of compound 3 (Fig. 5). An alkaline lysis solution was used to detect the possible double and single strand DNA breaks. Hydrogen peroxide was used as positive control. Formation of DNA breaks could easily be seen for 53% MIA PaCa-2 cells treated with 5μM of 4′-methylklavuzon (3), although total number of the apoptotic cells was around 14% of the total cell population. A similar inconsistency was also found for MIA PaCa-2 cells treated with 10μM of compound 3. While only 20% of the cells were apoptotic at this concentration, 42% of the cell population gave comet as an indication of DNA breaks. Mismatch between the percentages of cells at apoptosis and percentages of cells giving comet can be explained by Topo I inhibition property of klavuzons. Topoisomerases, including topoisomerase I, play crucial role in the cellular response to DNA damage, DNA repair and apoptosis. Any damage in DNA cannot be repaired when all Topo I enzymes are inhibited by compound 3.